Literature DB >> 25766142

Comparison of experimental respiratory tularemia in three nonhuman primate species.

Audrey R Glynn1, Derron A Alves2, Ondraya Frick1, Rebecca Erwin-Cohen1, Aimee Porter1, Sarah Norris3, David Waag4, Aysegul Nalca5.   

Abstract

Tularemia is a zoonotic disease caused by Francisella tularensis, which is transmitted to humans most commonly by contact with infected animals, tick bites, or inhalation of aerosolized bacteria. F. tularensis is highly infectious via the aerosol route; inhalation of as few as 10-50 organisms can cause pneumonic tularemia. Left untreated, the pneumonic form has more than >30% case-fatality rate but with early antibiotic intervention can be reduced to 3%. This study compared tularemia disease progression across three species of nonhuman primates [African green monkey (AGM), cynomolgus macaque (CM), and rhesus macaque (RM)] following aerosolized F. tularensis Schu S4 exposure. Groups of the animals exposed to various challenge doses were observed for clinical signs of infection and blood samples were analyzed to characterize the disease pathogenesis. Whereas the AGMs and CMs succumbed to disease following challenge doses of 40 and 32 colony forming units (CFU), respectively, the RM lethal dose was 276,667 CFU. Following all challenge doses that caused disease, the NHPs experienced weight loss, bacteremia, fever as early as 4 days post exposure, and tissue burden. Necrotizing-to-pyogranulomatous lesions were observed most commonly in the lung, lymph nodes, spleen, and bone marrow. Overall, the CM model consistently manifested pathological responses similar to those resulting from inhalation of F. tularensis in humans and thereby most closely emulates human tularemia disease. The RM model displayed a higher tolerance to infection and survived exposures of up to 15,593 CFU of aerosolized F. tularensis. Published by Elsevier Ltd.

Entities:  

Keywords:  Aerosol; Animal model; Francisella tularensis; Inhalation; Nonhuman primate; Tularemia

Mesh:

Substances:

Year:  2015        PMID: 25766142      PMCID: PMC4397973          DOI: 10.1016/j.cimid.2015.01.003

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  11 in total

1.  Tularemia, biological warfare, and the battle for Stalingrad (1942-1943).

Authors:  E Croddy; S Krcálová
Journal:  Mil Med       Date:  2001-10       Impact factor: 1.437

2.  Detection of biological threat agents by real-time PCR: comparison of assay performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms.

Authors:  Deanna R Christensen; Laurie J Hartman; Bonnie M Loveless; Melissa S Frye; Michelle A Shipley; Deanna L Bridge; Michelle J Richards; Rebecca S Kaplan; Jeffrey Garrison; Carson D Baldwin; David A Kulesh; David A Norwood
Journal:  Clin Chem       Date:  2006-01       Impact factor: 8.327

3.  Steady-state minute volume determination by body-only plethysmography in juvenile rhesus monkeys.

Authors:  T K Besch; D L Ruble; P H Gibbs; M L Pitt
Journal:  Lab Anim Sci       Date:  1996-10

4.  Biological warfare. A historical perspective.

Authors:  G W Christopher; T J Cieslak; J A Pavlin; E M Eitzen
Journal:  JAMA       Date:  1997-08-06       Impact factor: 56.272

Review 5.  Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule.

Authors:  M V Stundick; M T Albrecht; C R Houchens; A Pierce Smith; T M Dreier; J C Larsen
Journal:  Vet Pathol       Date:  2013-04-29       Impact factor: 2.221

Review 6.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

Review 7.  Tularaemia: bioterrorism defence renews interest in Francisella tularensis.

Authors:  Petra C F Oyston; Anders Sjostedt; Richard W Titball
Journal:  Nat Rev Microbiol       Date:  2004-12       Impact factor: 60.633

8.  Pathology of inhalational Francisella tularensis spp. tularensis SCHU S4 infection in African green monkeys (Chlorocebus aethiops).

Authors:  N A Twenhafel; D A Alves; B K Purcell
Journal:  Vet Pathol       Date:  2009-03-09       Impact factor: 2.221

Review 9.  Pneumonic tularemia on Martha's Vineyard: clinical, epidemiologic, and ecological characteristics.

Authors:  Bela T Matyas; Henry S Nieder; Sam R Telford
Journal:  Ann N Y Acad Sci       Date:  2007-04-18       Impact factor: 5.691

Review 10.  Tularaemia: a challenging zoonosis.

Authors:  C L Carvalho; I Lopes de Carvalho; L Zé-Zé; M S Núncio; E L Duarte
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2014-01-13       Impact factor: 2.268

View more
  12 in total

1.  Region-Specific Transcriptional Control of Astrocyte Function Oversees Local Circuit Activities.

Authors:  Anna Yu-Szu Huang; Junsung Woo; Debosmita Sardar; Brittney Lozzi; Navish A Bosquez Huerta; Chia-Ching John Lin; Daniela Felice; Antrix Jain; Adriana Paulucci-Holthauzen; Benjamin Deneen
Journal:  Neuron       Date:  2020-04-21       Impact factor: 17.173

2.  The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.

Authors:  Trudy H Grossman; Michael S Anderson; David Christ; Melanie Gooldy; Lisa N Henning; Henry S Heine; M Victoria Kindt; Winston Lin; Kaylyn Siefkas-Patterson; Anne K Radcliff; Vincent H Tam; Joyce A Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4.

Authors:  Julie A Hutt; Julie A Lovchik; Alexander Dekonenko; Andrew C Hahn; Terry H Wu
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

4.  Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination.

Authors:  Ronit Aloni-Grinstein; Ofir Schuster; Shmuel Yitzhaki; Moshe Aftalion; Sharon Maoz; Ida Steinberger-Levy; Raphael Ber
Journal:  Front Microbiol       Date:  2017-02-28       Impact factor: 5.640

5.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

Review 6.  Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Authors:  Lydia M Roberts; Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-06       Impact factor: 5.293

7.  The Natural History of Aerosolized Francisella tularensis Infection in Cynomolgus Macaques.

Authors:  Ondraya M Frick; Virginia A Livingston; Chris A Whitehouse; Sarah L Norris; Derron A Alves; Paul R Facemire; Douglas S Reed; Aysegul Nalca
Journal:  Pathogens       Date:  2021-05-13

8.  Identification of an Attenuated Substrain of Francisella tularensis SCHU S4 by Phenotypic and Genotypic Analyses.

Authors:  Julie A Lovchik; Douglas S Reed; Julie A Hutt; Fangfang Xia; Rick L Stevens; Thero Modise; Eileen M Barry; Terry H Wu
Journal:  Pathogens       Date:  2021-05-22

Review 9.  Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis.

Authors:  Qingmei Jia; Marcus A Horwitz
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

10.  Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.

Authors:  Katherine J O'Malley; Jennifer D Bowling; Elizabeth Stinson; Kelly S Cole; Barbara J Mann; Prachi Namjoshi; Karsten R O Hazlett; Eileen M Barry; Douglas S Reed
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.